WEBINAR | COVID-19 pre-exposure prophylaxis (prevention) with monoclonal antibodies

Monoclonal antibodies may play an important role in preventing COVID-19 in people who do not have healthy immune systems and can be engineered to be long-acting. Currently there is only one pre-exposure long acting monoclonal antibody (LAAB) available in Canada for the prevention of COVID-19.

During this webinar, participants learned about the need for monoclonal antibodies for the prevention of COVID-19 in specific populations and presenters discussed the science of monoclonal antibodies and explained the eligibility criteria to receive monoclonal antibodies.


Leave a Reply